Gilead Sciences Inc. (GILD) News Nov 20, 2014, 6:58

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 7:20 PM

Gilead Sciences Inc. (GILD) News Nov 20, 2014, 6:58 p.m.
MarketWatch News on GILD
Gilead Sciences shares slide 1.7% 9:35 a.m. Nov. 19, 2014 - Sue Chang
Are consumers getting gouged on health care? 12:58 p.m. Nov. 18, 2014 - Russ Britt
The double-edged sword of growth-stock speculation 2:29 p.m. Nov. 14, 2014 - The Trading Deck
10 S&P 500 companies with the fastest revenue growth 8:28 a.m. Nov. 11, 2014 - Philip van Doorn
Merck, Dendreon miss out on health-care rally 12:39 p.m. Nov. 10, 2014 - Russ Britt
Gilead Sciences rises 2% to top S&P 500 gainers 9:31 a.m. Nov. 10, 2014 - Sue Chang
Visa shares rise after hours on earnings beat 6:50 p.m. Oct. 29, 2014 - Sue Chang
Warren Buffett best wear his trunks as Fed preps to end (pause) the printing 8:34 a.m. Oct. 29, 2014 - Shawn Langlois
Facebook, Gilead shares fall after hours 6:14 p.m. Oct. 28, 2014 - Sue Chang
Updates, advisories and surprises 5:01 p.m. Oct. 28, 2014 - MarketWatch
Sales of Gilead's pricey hepatitis C drug slow 4:26 p.m. Oct. 28, 2014 - MarketWatch.com
Gilead Sciences' stock pulls back from record high close after earnings miss 4:14 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead's stock drops 3.6% in after-hours trade after Q3 results 4:09 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead revises 2014 product sales outlook to $22 bln-$23 bln from $21 bln-$23 bln 4:08 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 Sovaldi sales $2.8 bln vs. $3.48 bln in Q2 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales top FactSet consensus estimate of $5.99 bln 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 sales $6.04 bln vs. $2.78 bln a year ago 4:07 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Q3 net EPS $1.67 vs. 47 cents a year ago 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Gilead Sciences Q3 adj. EPS $1.84 vs. FactSet consensus $1.92 4:06 p.m. Oct. 28, 2014 - Tomi Kilgore
Two biotech leaders to watch 2:12 p.m. Oct. 28, 2014 - The Trading Deck

Other News on GILD
Gilead to Buy Knight Therapeutics' Priority Review Voucher - Analyst Blog 4:27 p.m. Today - Zacks.com
France gets larger discount on Sovaldi than its neighbors 12:04 p.m. Today - Seeking Alpha
Global drug tab will breach trillion dollar mark this year 7:41 a.m. Today - Seeking Alpha
CNBC's Stock Pops & Drops From November 19 6:38 a.m. Today - benzinga.com
Gilead Gains on Harvoni's EU Approval for HCV Treatment - Analyst Blog 5:57 p.m. Nov. 19, 2014 - Zacks.com
Why We're Huge Fans Of Gilead 4:33 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead buys FDA voucher for $125M 3:59 p.m. Nov. 19, 2014 - Seeking Alpha
Gilead: Pipeline Now Includes Potential Renal Blockbuster 11:35 a.m. Nov. 19, 2014 - Seeking Alpha
Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog 11:23 a.m. Nov. 19, 2014 - Zacks.com
Update: Gilead's Harvoni Receives Marketing Authorization In Europe 11:17 a.m. Nov. 19, 2014 - Seeking Alpha
Stock Market News for November 19, 2014 - Market News 10:10 a.m. Nov. 19, 2014 - Zacks.com
Stock Market Today: Oil Slump Fuels S&P 500 to Fresh Record High 4:09 p.m. Nov. 18, 2014 - TheStreet.com
Gilead's Value Without Its Hep C Franchise 4:07 p.m. Nov. 18, 2014 - Seeking Alpha
Stock Market Today: S&P 500 Notches New High as Oil Prices Slip and Slide 2:23 p.m. Nov. 18, 2014 - TheStreet.com
Stock Movers: Why 4 Big Drug Stocks Are Rising Today 1:38 p.m. Nov. 18, 2014 - Investors Business Daily
Gilead Sciences (GILD) Stock Rises After European Commission Market Authorization for Harvoni 10:48 a.m. Nov. 18, 2014 - TheStreet.com
Buy Gilead Sciences Now At A Historic Low Valuation 8:52 a.m. Nov. 18, 2014 - Seeking Alpha
Dispelling Some Of The Myths Surrounding Gilead Sciences. 8:22 a.m. Nov. 18, 2014 - Seeking Alpha
Trade of the Day: Gilead Sciences (GILD) 3:16 a.m. Nov. 18, 2014 - InvestorPlace.com
Trade of the Day: Gilead Sciences Stock on Sale 7:56 p.m. Nov. 17, 2014 - InvestorPlace.com

Press Releases on GILD
Earnings Forecast Report for Yahoo, Alibaba, Cliffs Natural Resources, Gilead Sciences, Apple, and Plug Power 8:45 a.m. Today - PR Newswire - PRF
Knight Sells Priority Review Voucher to Gilead 5:11 p.m. Nov. 19, 2014 - Marketwired
European Commission Grants Marketing Authorization for Gilead’s Harvoni®▼ (Ledipasvir/Sofosbuvir), the First Single Tablet Regimen to Treat the Majority of Chronic Hepatitis C Patients With Genotype 1 and 4 10:07 a.m. Nov. 18, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Baker Hughes, Halliburton, Apple, Gilead Sciences, Kinder Morgan, and Alibaba 8:45 a.m. Nov. 18, 2014 - PR Newswire - PRF
Equity Coverage on Biotech Industry - Gilead Sciences, MannKind, ARIAD Pharma, iBio Inc., and Celgene 9:10 a.m. Nov. 14, 2014 - PR Newswire - PRF
Reveal Earnings Forecast for BlackBerry, Twitter, Alibaba, Sirius XM, Gilead Sciences, and JD.Com 8:45 a.m. Nov. 14, 2014 - PR Newswire - PRF
Gilead Prices $4 Billion of Senior Unsecured Notes 5:59 p.m. Nov. 12, 2014 - BusinessWire - BZX
Earnings Forecast Recap for Alibaba, Apple, Zynga, Gilead Sciences, Dendreon, and Juniper 8:45 a.m. Nov. 12, 2014 - PR Newswire - PRF
Gilead Announces Phase 2 Data for Investigational All-Oral Regimen of Sofosbuvir Plus GS-5816 for the Treatment of Chronic Hepatitis C 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Gilead Announces Harvoni Study Results in Chronic Hepatitis C Patients with Advanced Liver Disease and Those Who Failed Prior Treatment 8:02 a.m. Nov. 11, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, Genworth Financial, Gilead Sciences, Zynga, Abercrombie & Fitch, and Plug Power 8:45 a.m. Nov. 10, 2014 - PR Newswire - PRF
Medifocus to Be Broadcast on BNN and Fox Business News on November 8th and 9th, 2014 10:56 a.m. Nov. 7, 2014 - Marketwired
Linkage Biosciences Adds to Board Leadership 8:02 a.m. Nov. 7, 2014 - Marketwired
Critical Alerts For Delta Airlines, ConocoPhillips, Qualcomm, Kinder Morgan and Gilead Sciences Released By InvestorsObserver 9:31 a.m. Nov. 6, 2014 - PR Newswire - PRF
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Tenofovir Alafenamide (TAF)-Based Single Tablet Regimen for HIV 8:32 a.m. Nov. 6, 2014 - BusinessWire - BZX
Earnings Forecast Buzz for Alibaba, GT Advanced Technologies, GoPro, Plug Power, Gilead Sciences, and American Realty Capital Properties 8:45 a.m. Nov. 4, 2014 - PR Newswire - PRF
Life-Science New Build Report: 200 New North American Sites in Planning Represent Potential $15 Billion Investment, an Industrial Info News Alert 6:16 a.m. Nov. 4, 2014 - Marketwired
Gilead Sciences Once Again Tops the List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 6:15 a.m. Nov. 4, 2014 - Marketwired
Earnings Forecast Buzz for American Realty Capital Properties, Alibaba, Petroleo Brasileiro Petrobras SA, Gilead Sciences, RF Micro Devices, and GoPro 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly 8:35 a.m. Oct. 29, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cuisine.K Brings Korean Seafood to Seattle Spotlight

Korean Seafood Makes Waves in Seattle Bring out the chopsticks, ‘cause Korean seafood just took Seattle by storm with the Cuisine.K Korean culinary showcase. Hosted by CJ Foods, alongside the Korea Fisheries Association, this event smacked the local food scene square in the face with the unique flavors and techniques of K-Seafood—from students all the way to seasoned...

Microsoft's Cloud Misstep: Recovery Plans in Focus

Microsoft's Stumble Puts CIOs on Alert Thursday's Microsoft 365 outage, a wrench in the works for every firm that ties its daily operations to these cloud services, has brought some harsh truths to the table. On November 12, outages hit users hard, preventing access to Exchange Online mailboxes and sending ripples through Teams, SharePoint, Copilot, and Defender. You...

LEOTEK's AI Tech Shaping Smarter Cities at COP31

AI-Powered Evolution in Urban Infrastructure Hang on to your hats, folks, 'cause LEOTEK is turning heads at COP31 with its AI-driven transformation of urban landscapes. As cities stretch at the seams to keep up with modern challenges, LEOTEK's got more than a few tricks up its sleeve with its trademark blend of traffic system intelligence and energy management prowess....

Foreigner to Rock Irvine with Night Ranger in 2027

Irvine Set for a Rock Revival Talk about a blast from the past! On March 27, 2027, two titans of the rock world, Foreigner and Night Ranger, are set to ignite Irvine like it's the glory days of arena rock all over again. Hosted at the Great Park Live, this show isn't just a concert—it's a full-scale invasion of rock's golden age right into Southern California's heart....

ManuTech Center Set to Revolutionize Manufacturing Hub

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

El Pollo Loco Faces Class Action Over Wage Practices

Alright, here's where things start sizzling—El Pollo Loco, the fast-food chicken chain whose name translates to 'The Crazy Chicken'—is in a legal pickle. The lawsuit hanging over their heads could spell a sticky situation for them and possibly ripple through the fast-food industry. The suit, filed by the steadfast firm Blumenthal Nordrehaug Bhowmik De Blouw LLP, has...

PangeAI and Sky Blue Transform Data Center Decisions

Just when you thought the incessant trials of picking a prime data center site couldn’t get any more grueling or expensive, enter PangeAI and its brand-new ally, Sky Blue Impact. These tech firms have partnered up to speed up what has traditionally been a sluggish, pricey process. Here’s the deal: PangeAI’s geospatial AI platform lets Sky Blue dodge the usually...

Retirement Dreams Dashed: 61% Withdraw Early

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

Wiz Khalifa Ignites MJBizCon 2026 with Keynote and Music

An Icon in Cannabis Culture Hits the Stage When you mix business with pleasure, you get something like what MJBizCon's cooking up this year. Wiz Khalifa, the man with a knack for turning passion into profit, is jumping onto the stage—not just as a performer, but also as a keynote speaker. On December 2, attendees are in for a treat as he steps into a new spotlight at...

Later's NYC Summit Reinvents Social Commerce Game Plan

Creators and Corporates Collide Imagine this: an NYC stage not adorned with Broadway's finest, but with digital maestros steering a new age in social commerce. That's what Later is betting on with their Creator Live summit, debuting in the bustling heart of New York City. We're talking about influencers not just as Instagram stars, but as key players in a $480 billion...